Mepriam en es it fr

Mepriam Brand names, Mepriam Analogs

Mepriam Brand Names Mixture

  • No information avaliable

Mepriam Chemical_Formula


Mepriam RX_link

No information avaliable

Mepriam fda sheet

Mepriam msds (material safety sheet)

Mepriam Synthesis Reference

No information avaliable

Mepriam Molecular Weight

309.469 g/mol

Mepriam Melting Point

< 25 oC

Mepriam H2O Solubility

Soluble as HCl salt

Mepriam State


Mepriam LogP


Mepriam Dosage Forms

Tablets (oral, 1 mg)

Mepriam Indication

Used for the symptomatic treatment of parkinsonism.

Mepriam Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Mepriam Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Mepriam side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Mepriam Patient Information

Mepriam Organisms Affected

Humans and other mammals